Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-06-01 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
CGIX | Cancer Genetics | 5.63 | 0.38 | 7.24% | 59.5M |
You can purchase shares of Cancer Genetics (NASDAQ: CGIX) through any online brokerage.
Other companies in Cancer Genetics’s space includes: Brickell Biotech (NASDAQ:BBI), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Edesa Biotech (NASDAQ:EDSA).
The latest price target for Cancer Genetics (NASDAQ: CGIX) was reported by Maxim Group on 2018-04-03. The analyst firm set a price target for 0.00 expecting CGIX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Cancer Genetics (NASDAQ: CGIX) is $5.63 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cancer Genetics.
There is no upcoming split for Cancer Genetics.